Integra Lifesciences's total assets for Q2 2025 were $3.67B, a decrease of -9.50% from the previous quarter. IART total liabilities were $2.63B for the fiscal quarter, a 3.98% a decrease from the previous quarter. See a summary of the company’s assets, liabilities, and equity.